Biopharma CreditBOPCF
13F holders, Q1 2026 (March 31)1holders
0new positions
0sold out
$0.93avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding Biopharma Credit PLC (BOPCF) in their 13F filings, unchanged from Q4 2025. 0 opened new positions and 0 sold out. The largest holder was Aubrey Capital Management Ltd ($840K).
- Company
- Biopharma Credit PLC
- CUSIP
- G12808104
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 2,050,990 shares sold, net −2,050,990 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Aubrey Capital Management Ltd | 0.45% | Reduce -69.5% | 900,000 | $840K |
"% of holder's portfolio" is BOPCF's weight in each manager's 13F, not the share of Biopharma Credit PLC the manager owns.